Abstract
Until recently, therapy for patients with severe congenital dyserythropoietic anemia (CDA) has been limited to blood transfusions and chelation therapy. Three children with transfusion-dependent CDA type I underwent allogeneic stem cell transplantation (SCT) from matched sibling donors. Conditioning was with cyclophosphamide 50 mg/kg/day for 4 days, busulphan 4 mg/kg/day for 4 days, and antithymocyte globulin (ATG) 30 mg/kg for four doses pre-SCT. All patients engrafted and are alive, and transfusion independent. To our knowledge, this is the first report of successful SCT in the management of CDA type I.
Your institute does not have access to this article
Access options
Subscribe to Journal
Get full journal access for 1 year
$119.00
only $9.92 per issue
All prices are NET prices.
VAT will be added later in the checkout.
Tax calculation will be finalised during checkout.
Buy article
Get time limited or full article access on ReadCube.
$32.00
All prices are NET prices.
References
Shalev H, Tamary H, Shaft D et al. Neonatal manifestations of congenital dyserythropoietic anemia type I J Pediatr 1997 131: 95 97
Wickramasinghe SN . Congenital dyserythropoietic anemias Curr Opin Hematol 2000 7: 71 78
Tamary H, Shalev H, Pinsk V et al. No response to recombinant human erythropoietin therapy in patients with congenital dyserythropoietic anemia type I Pediatr Hematol Oncol 1999 16: 165 168
Lavabre-Bertrand T, Blanc P, Navarro R et al. Alpha-interferon therapy for congenital dyserythropoiesis type I Br J Haematol 1995 89: 929 932
Virjee S, Hatton C . Congenital dyserythropoiesis type I and alpha-interferon therapy Br J Haematol 1996 94: 581 582
Parez N, Dommergues M, Zupan V et al. Severe congenital dyserythropoietic anaemia type I: prenatal management, transfusion support and alpha-interferon therapy Br J Haematol 2000 110: 420 423
Shamseddine A . Taher A. Jaafar H et al. Interferon alpha is an effective therapy for congenital dyserythropoietic anaemia type I Eur J Haematol 2000 65: 207 209
Lucarelli G, Galimberti M, Polchi P et al. Bone marrow transplantation in patients with thalassemia New Engl J Med 1990 322: 417 421
Giardini C, Lucarelli G . Bone marrow transplantation for beta-thalassemia Hematol Oncol N Am 1999 13: 1059 1064
Ayas M, Al-Jefri A, Mustafa M et al. Congenital sideroblastic anaemia successfully treated using allogeneic stem cell transplantation Br J Haematol 2001 113: 938 939
Urban C, Binder B, Hauer C, Lanzer G . Congenital sideroblastic anemia successfully treated by allogeneic bone marrow transplantation Bone Marrow Transplant 1992 10: 373 375
González MI, Caballero D, Vázquez L et al. Allogeneic peripheral stem cell transplantation in hereditary sideroblastic anaemia Br J Haematol 2000 109: 658 660
Iolascon A, Sabato V, De Mattia D, Locatelli F . Bone marrow transplantation in a case of severe, type II congenital dyserythropoietic anaemia (CDA II) Bone Marrow Transplant 2001 27: 213 21
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Ayas, M., Al-Jefri, A., Baothman, A. et al. Transfusion-dependent congenital dyserythropoietic anemia type I successfully treated with allogeneic stem cell transplantation. Bone Marrow Transplant 29, 681–682 (2002). https://doi.org/10.1038/sj.bmt.1703526
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bmt.1703526
Keywords
- stem cell transplantation
- dyserythropoietic anemia
- congenital anemia
- ineffective erythropoiesis
- interferon
Further reading
-
Non-myeloablative allogeneic stem cell transplant with post-transplant cyclophosphamide cures the first adult patient with congenital dyserythropoietic anemia
Bone Marrow Transplantation (2017)
-
Congenital dyserythropoietic anemia
International Journal of Hematology (2010)